Concepedia

Sarah E. Dowdell

SE

Statistics

Publications

10

Citations

534

H-Index

10

Active since

2004

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

GlaxoSmithKline (United Kingdom)

Pathways Behavioral Services

South College

Sarah E. Dowdell is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2004–2018

10

Publications

10

Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors

Krista Goodman, Haifeng Cui, Sarah E. Dowdell et al. · Journal of Medicinal Chemistry · 2006 · 156 citations · Full text

, , +17

Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4

Mui Cheung, Weike Bao, David J. Behm et al. · ACS Medicinal Chemistry Letters · 2017 · 99 citations · Full text

, , +10

Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases

Clark A. Sehon, Gren Z. Wang, Andrew Q. Viet et al. · Journal of Medicinal Chemistry · 2008 · 72 citations · Full text

, , +13

Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity

Robert A. Stavenger, Haifeng Cui, Sarah E. Dowdell et al. · Journal of Medicinal Chemistry · 2006 · 71 citations · Full text

, , +17

Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors

Krista Goodman, Michael J. Bury, Mui Cheung et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 52 citations · Full text

, , +10

1–5 of 10